Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
- PMID: 1401070
- PMCID: PMC443180
- DOI: 10.1172/JCI116001
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
Abstract
The epidermal growth factor (EGF) receptor is activated by both EGF and transforming growth factor-alpha (TGF-alpha). Using immunohistochemical and immunoblotting techniques we now report that the EGF receptor, EGF, and TGF-alpha are found in both pancreatic acini and ducts in the normal human pancreas, and that all three proteins are expressed at higher levels in human pancreatic cancer tissues. Using in situ hybridization techniques, we also report that the mRNA encoding the EGF receptor, EGF, and TGF-alpha colocalize with their respective proteins. Northern blot analysis of total RNA indicates that, by comparison with the normal pancreas, the pancreatic tumors exhibit a 3-, 15-, and 10-fold increase in the mRNA levels encoding the EGF receptor, EGF, and TGF-alpha, respectively. Furthermore, by in situ hybridization, there is a marked increase in these mRNA moieties within the tumor mass. These findings suggest that EGF and TGF-alpha may participate in the regulation of normal pancreatic exocrine function, and that overexpression of the EGF receptor and its two principal ligands may contribute to the pathophysiological processes that occur in human pancreatic cancer.
Similar articles
-
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.Anticancer Res. 1993 May-Jun;13(3):565-9. Anticancer Res. 1993. PMID: 8317885
-
Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.Mod Pathol. 1994 Sep;7(7):741-6. Mod Pathol. 1994. PMID: 7824507
-
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer.J Pathol. 1991 Feb;163(2):111-6. doi: 10.1002/path.1711630206. J Pathol. 1991. PMID: 1707959
-
Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.J Recept Signal Transduct Res. 2000 Jan;20(1):1-46. doi: 10.3109/10799890009150035. J Recept Signal Transduct Res. 2000. PMID: 10711495 Review.
-
Potential role of the epidermal growth factor receptor in human pancreatic cancer.Int J Pancreatol. 1990 Aug-Nov;7(1-3):71-81. doi: 10.1007/BF02924222. Int J Pancreatol. 1990. PMID: 2081930 Review.
Cited by
-
Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis.Gut. 1999 Oct;45(4):605-12. doi: 10.1136/gut.45.4.605. Gut. 1999. PMID: 10486373 Free PMC article.
-
Biology and management of pancreatic cancer.Gut. 2007 Aug;56(8):1134-52. doi: 10.1136/gut.2006.103333. Gut. 2007. PMID: 17625148 Free PMC article. Review. No abstract available.
-
Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.Int J Pancreatol. 2001;29(2):85-92. doi: 10.1385/IJGC:29:2:085. Int J Pancreatol. 2001. PMID: 11876253
-
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.Gut. 2019 Apr;68(4):742-758. doi: 10.1136/gutjnl-2018-316822. Epub 2018 Nov 5. Gut. 2019. PMID: 30396902 Free PMC article. Review.
-
(-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2.Mol Pharm. 2009 Jul-Aug;6(4):1152-9. doi: 10.1021/mp900037p. Mol Pharm. 2009. PMID: 19438225 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials